more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$415.54 USD

+9.06 (2.23%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $415.66 +0.12 (0.03%) 6:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5 2

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

Top 5% (13 out of 250)

Industry: Medical - Hospital

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Hold on to Universal Health (UHS) Now

by Zacks Equity Research Published on March 04,2021

Riding high on its solid segments and an impressive top line, Universal Health (UHS) holds enough potential to reap benefits for investors.

medical

Universal Health (UHS) Q4 Earnings Beat, Revenues Up Y/Y

by Zacks Equity Research Published on March 01,2021

Universal Health's (UHS) fourth-quarter results reflect improved revenues across the company's segments, partly offset by elevated costs.

medical

Select Medical (SEM) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research Published on February 26,2021

Select Medical's (SEM) Q4 results reflect solid performances by its Critical Illness Recovery and Rehabilitation Hospital segments.

Acadia Healthcare (ACHC) Q4 Earnings Top Estimates, Rise Y/Y

by Zacks Equity Research Published on February 26,2021

Acadia Healthcare's (ACHC) Q4 results reflect progress in its U.S business, which gained from solid volumes, and its solid cost-management policy.

medical

Universal Health (UHS) to Report Q4 Results: What to Expect?

by Zacks Equity Research Published on February 22,2021

Universal Health's (UHS) fourth-quarter results are likely to reflect gain from better revenues.

medical

MEDNAX's (MD) Q4 Earnings Fall Shy of Estimates, Tumble Y/Y

by Zacks Equity Research Published on February 19,2021

MEDNAX's (MD) fourth-quarter results reflect muted revenues caused by the COVID-19 pandemic.

Community Health's (CYH) Q4 Earnings Surpass, Improve Y/Y

by Zacks Equity Research Published on February 18,2021

Community Health's (CYH) fourth-quarter earnings gain from lower costs. However, the same is offset to some extent by soft admissions.

4 Hospital Stocks to Gain From Growth in Patient Admissions

by Sapna Bagaria Published on February 15,2021

Players in the hospital industry are likely to gain from increasing patient admissions, government grants and cost-control measures.

medical

Molina Healthcare (MOH) Posts Q4 Loss, Misses on Revenues

by Zacks Equity Research Published on February 11,2021

Molina Healthcare's (MOH) fourth-quarter results reflect escalating expenses.

Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research Published on February 10,2021

Tenet Healthcare's (THC) Q4 earnings improve on the back of better revenues.

Centene (CNC) Q4 Earnings Surpass Estimates, Tumble Y/Y

by Zacks Equity Research Published on February 09,2021

Centene (CNC) Q4 results gain from improved revenues as well as better membership.

The Zacks Analyst Blog Highlights: Sony, Mondelez International, Twilio, Workday and HCA Healthcare

by Zacks Equity Research Published on February 05,2021

The Zacks Analyst Blog Highlights: Sony, Mondelez International, Twilio, Workday and HCA Healthcare

Q4 Earnings Scorecard and Analyst Reports for Sony, Mondelez & Twilio

by Sheraz Mian Published on February 04,2021

We have provided a real-time update on the Q4 earnings season, in addition to featuring new research reports on 16 major stocks in today's Research Daily.

Ensign Group's (ENSG) Q4 Earnings Top Estimates, Improve Y/Y

by Zacks Equity Research Published on February 04,2021

Ensign Group's (ENSG) fourth-quarter results reflect a year-over-year rise in revenues.

Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y

by Zacks Equity Research Published on February 03,2021

Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.

HCA Healthcare's (HCA) Q4 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research Published on February 02,2021

HCA Healthcare's (HCA) fourth-quarter earnings gain on the back of better revenues.

HCA Holdings (HCA) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research Published on February 02,2021

HCA (HCA) delivered earnings and revenue surprises of 13.77% and 2.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?